A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
At the end of June, on a quiet, tree-lined street in the Back Mountain, Frank Shiner stood outside an old farmhouse, staring ...
Contribute to EsmailLeath/Alemdar development by creating an account on GitHub.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results